seborrheic dermatitis
Conditions
Interventions
Experimental group :Using an appropriate amount of Shenbai Lotion externally and rubing it to foam. After massaging the scalp for 3-5 minutes, rinse thoroughly with water and use it every other day, 3
Control group :Using an appropriate amount of 2% ketoconazole lotion externally and rubing it to foam. After massaging the scalp for 3-5 minutes, rinse thoroughly with water and use it every other day
Sponsors
Guangzhou Institute of Dermatology
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1\Subjects aged 18 to 60 years (including 18 and 60 years old) diagnosed with mild to moderate seborrheic dermatitis of the scalp, regardless of gender\2\Subjects recieved no systemic or local application of antibiotics, antifungal drugs, corticosteroids, or other drugs for the treatment of seborrheic dermatitis within 4 weeks;3\There is no severe hair loss, with hair growth covering at least 70% of the scalp;4\The participants should sign an informed consent and comply with medical advice.
Exclusion criteria
Exclusion criteria: 1\Subjects have used systemic or local antibiotics, antifungal drugs, corticosteroids, and other drugs to treat seborrheic dermatitis in the past 4 weeks;2\Scalp has co-exist with other conditions;3\Those who suffering from serious systemic diseases, which may affect the evaluators of the results, such as autoimmune diseases, arrhythmia, liver and kidney diseases, blood system diseases, malignant tumors, chronic severe infections, diabetes, psychosis;4\Those who have participated or are currently participating in other clinical trials within 3 months;5\Having pegnancy, lactation, or planned pregnancy during the study period;6\Individuals who are known to be allergic to the ingredients of this medicine;7\Subjects is not possible to give full informed consent due to mental and behavioral disorders;8\Subjects should be exclued according to the researcher's judgment, such as frequent changes in the work environment and other pathological changes that reduce the likelihood of enrollment or complicate enrollment, which may easily lead to loss of follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pruritus score;Erythema score;IGA score;Dandruff score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug tolerance assessment; | — |
Countries
China
Contacts
Public Contactyexingdong
Guangzhou Institute of Dermatology
Outcome results
None listed